Evidence map›Paper›PMID 42430260›Full record

ArticleACS applied materials & interfaces2026

Photothermal-Chemotherapeutic Microneedle Patch Coloaded with HMnO

Xuewei Zhang, Yixun Zhang, Lujia Mao, Xin Zhou, Jie Huang, Deni Kang, Sirong Liu, Mingjuan Chen, Ronghua Yang

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xuewei ZhangDepartment of Burn and Plastic Surgery, Guangzhou First People's Hospital, Guangzhou, Guangdong 510180, China.ORCID 0009-0005-7464-8701
Yixun ZhangDepartment of Burn and Plastic Surgery, Guangzhou First People's Hospital, Guangzhou, Guangdong 510180, China.
Lujia MaoDepartment of Burn and Plastic Surgery, Guangzhou First People's Hospital, Guangzhou, Guangdong 510180, China.
Xin ZhouDepartment of Burn and Plastic Surgery, Guangzhou First People's Hospital, Guangzhou, Guangdong 510180, China.
Jie HuangDepartment of Burn and Plastic Surgery, Guangzhou First People's Hospital, Guangzhou, Guangdong 510180, China.
Deni KangDepartment of Burn and Plastic Surgery, Guangzhou First People's Hospital, Guangzhou, Guangdong 510180, China.
Sirong LiuDepartment of Burn and Plastic Surgery, Guangzhou First People's Hospital, Guangzhou, Guangdong 510180, China.
Mingjuan ChenDepartment of Burn and Plastic Surgery, Guangzhou First People's Hospital, Guangzhou, Guangdong 510180, China.
Ronghua YangDepartment of Burn and Plastic Surgery, Guangzhou First People's Hospital, Guangzhou, Guangdong 510180, China.ORCID 0000-0002-9685-7003

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgical resection remains the primary mode of treatment for melanoma. However, postoperative tumor recurrence and impaired wound healing significantly compromise the patient prognosis. In this study, we developed a microneedle (MN) patch coloaded with HMnO

Indexed as

DoxorubicinMelanomaAnimalsCell Line, TumorFemaleHumansMiceMicroneedle Drug DeliveryNeedlesPercutaneous Collagen InductionPhotothermal TherapyWound HealingDoxorubicinhydroxydaunorubicinmelanomamicroneedle patchphotothermal ablationpostoperative managementwound healing

Identifiers

PMID42430260
PMCPMC13397482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.